ES2200706A1 - Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents - Google Patents

Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents

Info

Publication number
ES2200706A1
ES2200706A1 ES200201938A ES200201938A ES2200706A1 ES 2200706 A1 ES2200706 A1 ES 2200706A1 ES 200201938 A ES200201938 A ES 200201938A ES 200201938 A ES200201938 A ES 200201938A ES 2200706 A1 ES2200706 A1 ES 2200706A1
Authority
ES
Spain
Prior art keywords
bipyridyl
bistiazoles
bisoxazoles
derivatives
antineoplasic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200201938A
Other languages
Spanish (es)
Other versions
ES2200706B1 (en
Inventor
Sanchez Cantalejo Yolan Martin
Hormaeche Maria Jesus Villa
Pizarro Beatriz Saez
Romero Javier Soto
Brana Miguel Fernandez
Sanjuan Juan Carlos Lacal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Universidad Europea de Madrid SA
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Universidad Europea de Madrid SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Universidad Europea de Madrid SA filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to ES200201938A priority Critical patent/ES2200706B1/en
Priority to PCT/ES2003/000424 priority patent/WO2004016622A1/en
Priority to AU2003260515A priority patent/AU2003260515A1/en
Publication of ES2200706A1 publication Critical patent/ES2200706A1/en
Application granted granted Critical
Publication of ES2200706B1 publication Critical patent/ES2200706B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to novel derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles, having general formula I with antiproliferative activity and, more specifically, malignant cells such as HT-29. The invention also relates to the industrial production method for same and to the use thereof in the development of pharmaceutical compounds for the treatment of human tumours.
ES200201938A 2002-08-16 2002-08-16 DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS. Expired - Fee Related ES2200706B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES200201938A ES2200706B1 (en) 2002-08-16 2002-08-16 DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS.
PCT/ES2003/000424 WO2004016622A1 (en) 2002-08-16 2003-08-14 Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents
AU2003260515A AU2003260515A1 (en) 2002-08-16 2003-08-14 Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200201938A ES2200706B1 (en) 2002-08-16 2002-08-16 DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS.

Publications (2)

Publication Number Publication Date
ES2200706A1 true ES2200706A1 (en) 2004-03-01
ES2200706B1 ES2200706B1 (en) 2005-06-01

Family

ID=31725576

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200201938A Expired - Fee Related ES2200706B1 (en) 2002-08-16 2002-08-16 DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS.

Country Status (3)

Country Link
AU (1) AU2003260515A1 (en)
ES (1) ES2200706B1 (en)
WO (1) WO2004016622A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2344780B1 (en) * 2009-03-03 2011-07-22 Universidad De Barcelona USEFUL BISTIAZOLIC COMPOUNDS FOR THE TREATMENT OF CANCER.
ES2543918T3 (en) 2010-09-02 2015-08-25 Universitat De Barcelona Fluorinated thiazoles useful for cancer treatment

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148194A (en) * 1961-07-03 1964-09-08 Arapahoe Chemicals Inc Certain 1, 4-bis[2(4-substituted, 5-phenyloxazolyl)] benzenes
FR2066252A5 (en) * 1970-10-20 1971-08-06 Sumitomo Chemical Co Oxazolyl optical brighteners for textiles and plastics
DD260698A1 (en) * 1986-11-27 1988-10-05 Tech Hochschule C Schorlemmer METHOD FOR THE PRODUCTION OF BIS-OXAZOLIUM SALTS
JP2000318313A (en) * 1999-05-07 2000-11-21 Mitsui Chemicals Inc Optical recording medium

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148194A (en) * 1961-07-03 1964-09-08 Arapahoe Chemicals Inc Certain 1, 4-bis[2(4-substituted, 5-phenyloxazolyl)] benzenes
FR2066252A5 (en) * 1970-10-20 1971-08-06 Sumitomo Chemical Co Oxazolyl optical brighteners for textiles and plastics
DD260698A1 (en) * 1986-11-27 1988-10-05 Tech Hochschule C Schorlemmer METHOD FOR THE PRODUCTION OF BIS-OXAZOLIUM SALTS
JP2000318313A (en) * 1999-05-07 2000-11-21 Mitsui Chemicals Inc Optical recording medium

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Patent Abstract of Japan [CD ROM] & JP 2000318313 A (YAMAMOTO CHEM INC) 21.11.2000 (resumen) *
RICE, C. et al.: New multidentate ligands for supramolecular coordination chemistry: double and triple helical complexes of ligands containing pyridil and thiazol donor units. J. Chem. Society, Dalton Transactions, 2001, Vol. 5, paginas 550-559. Pagina 551, conjunto L3. *

Also Published As

Publication number Publication date
AU2003260515A1 (en) 2004-03-03
AU2003260515A8 (en) 2004-03-03
ES2200706B1 (en) 2005-06-01
WO2004016622A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
GB0223038D0 (en) Therapeutic compounds
HK1075450A1 (en) heterocyclic compunds, process for their preparation and pharmaceutical compositions containing thenm and thier use in medicine
MY132106A (en) New pyridazin-3(2h)-one derivatives
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
IL173203A0 (en) Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
HK1057752A1 (en) N-phenyl-2-pyrimidine-amine derivatives
HK1083624A1 (en) Hydroxyethylamine derivatives for the treatment ofalzheimer's disease
GEP20084528B (en) 5,7-DIAMINOPYRAZOLO [4,3-d] PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
SG148177A1 (en) Novel cis-imidazolines
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MXPA05007516A (en) Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments.
RS20050864A (en) Novel pyridopyrazines and use thereof as kinase inhibitors
MXPA05012645A (en) Novel pyridopyrazines and use thereof as kinase modulators.
HK1076812A1 (en) Cyanoguanidine prodrugs
DE602004017326D1 (en) TETRAHYDROCARBAZOL DERIVATIVES AND THEIR PHARMACEUTICAL USE
PL363679A1 (en) Novel use of 2-phenyl-substituted imidazotriazinones
IL159993A0 (en) Platinum complexes and their use in cancer treatment
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
MY133107A (en) Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia
UA83821C2 (en) Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
MXPA04001419A (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease.
GB0215526D0 (en) Anticancer compounds

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20040301

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2200706B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20211118